Announcements Trials
Browse Landscape

Phase

Phase NA 4

Status

Completed 28Not yet recruiting 4Recruiting 3Active not recruiting 2Withdrawn 1Unknown 1Terminated 1Suspended 1Enrolling by invitation 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 430Neoplasms 284Carcinoma, Non-Small-Cell Lung 266Colorectal Neoplasms 228Lung Neoplasms 173Prostatic Neoplasms 171Carcinoma, Hepatocellular 156Stomach Neoplasms 129Leukemia, Myeloid, Acute 118Pancreatic Neoplasms 115Multiple Myeloma 105Recurrence 96Uterine Cervical Neoplasms 91Squamous Cell Carcinoma of Head and Neck 88Neoplasm Metastasis 87Rectal Neoplasms 85Ovarian Neoplasms 77Triple Negative Breast Neoplasms 75Small Cell Lung Carcinoma 72Head and Neck Neoplasms 68Brain Neoplasms 68Esophageal Neoplasms 64Glioblastoma 63Colonic Neoplasms 60Endometrial Neoplasms 58Melanoma 54Hematologic Neoplasms 53Motor Activity 50Precursor Cell Lymphoblastic Leukemia-Lymphoma 48Nasopharyngeal Carcinoma 46

Interventions

Standard of Care 1Drug Delivery Systems 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Not yet recruiting × Interventional × Medication Adherence × Clear all
NCT07562399 2026-05-20

Adjuvant Endocrine Therapy Adherence Intervention Pilot in Rwanda

Dana-Farber Cancer Institute

Phase NA Not yet recruiting
224 enrolled
Breast

Breast Neoplasms, Medication Adherence

NCT06865755 2026-04-27

Collaborative Research: Multiscale Modeling and Intervention for Improving Long-Term Medication

San Diego State University

Phase NA Not yet recruiting
15 enrolled

Medication Adherence

NCT07273812 2026-04-21

AI-ChemoApp

University of Baghdad

Phase NA Not yet recruiting
130 enrolled
Breast

Breast Neoplasms, Neoplasms, Medication Adherence

NCT07223463 2025-10-31

A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer

Children's Hospital Medical Center, Cincinnati

Phase NA Not yet recruiting
160 enrolled

Neoplasms, Medication Adherence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡